The Bubble No One Can Sell | Dan Rasmussen on the Private Equity Trap

Episode Summary

Executive Summary: The episode argues that private equity is structurally over-loved, over-levered, and increasingly illiquid, with weak exit channels and overstated volatility benefits. Dan Wang traces how the Yale model once exploited true market inefficiencies, but says those advantages have largely disappeared. He also connects the debate to small-cap value, biotech, and AI, emphasizing that innovation often requires bubbles, yet today’s capital intensity may be creating new risks and lower future returns.

Main Topics: Private equity as an over-allocated, over-hyped asset class (Priority: 5/5): Dan argues that institutional portfolios are massively overweight private equity relative to the actual economic weight of the underlying companies, and that the industry’s popularity reflects consensus optimism rather than a durable edge. Why the Yale endowment model once worked (Priority: 5/5): The discussion explains how the endowment model emerged from the 1970s bond/equity slump and initially captured real inefficiencies in venture capital and private equity, before those opportunities became crowded. Liquidity, distributions, and weakening exit channels (Priority: 5/5): Private equity distributions are falling, fundraising is slowing, and the traditional exit paths—sales to other PE funds, strategic buyers, and IPOs—are all less effective, creating a 'money trap.' Volatility laundering and mismeasured risk (Priority: 4/5): Dan contends that private equity’s reported NAV volatility understates true risk because the underlying businesses are small and highly levered; public listings of PE funds show much higher market volatility. Small-cap value, public market replication, and sector composition (Priority: 4/5): The conversation links PE-style returns to levered small-cap value and argues that U.S. small-cap underperformance is partly driven by concentration in banks, biotech, and energy, unlike more diversified international small caps. Bubbles as a necessary ingredient for innovation (Priority: 4/5): The speakers acknowledge that speculative booms can be economically useful because they fund new company formation, even though most ventures fail and bubbles create losses for many investors. AI as a capital-intensive, potentially centralizing technology (Priority: 4/5): Dan praises AI’s usefulness but warns that its economics may resemble telecom more than Google: heavy capex, uncertain depreciation, and likely overspending by hyperscalers.

Key Arguments: Private equity is massively over-allocated in institutional portfolios: the underlying market is far smaller than the capital being committed to it. The original Yale-style endowment model made sense when private markets were underdeveloped and inefficient; today the space is crowded and expensive. Private equity’s best exits are deteriorating because PE-to-PE buyers have less money, strategics are slower, and IPO demand from active managers is limited. Reported private equity volatility is misleading; the true economic risk is higher because the assets are small, leveraged, and illiquid. Publicly listed private equity funds show that investors demand large discounts to NAV, implying skepticism about private valuations. U.S. small-cap value has been hurt by sector concentration in banks, biotech, and energy, while international small-cap value has had a healthier mix. Innovation often needs speculative excess, but that does not mean all speculative assets deserve high valuations. AI may be transformative, but its economics are more capital intensive than prior software revolutions, which could compress returns for infrastructure-heavy winners like hyperscalers.

Data Points: Private equity weight at pension funds: 15% - Dan says pension funds have around 15% of assets in private equity. Private equity weight at college endowments: 30% - Typical college endowments were cited as having about 30% in private equity. Private equity weight at elite college endowments: 40% - Elite college endowments were described as having around 40% in private equity. Belief private equity will outperform public equity: 90%+ - Surveyed investors overwhelmingly expect private equity to beat public equities. Expected annual outperformance: 200 bps net of fees - Median survey expectation for private equity outperformance over public equity. S&P 500 companies: 500 - Used as the benchmark for large public companies. S&P 500 aggregate market cap: about $50 trillion - Represents the scale of the largest public companies. Public companies outside S&P 500: about 2,000 - The next tier of public companies in the U.S. market discussion. Russell 2000 aggregate market cap: a little over $2 trillion - Used to compare U.S. small caps to the S&P 500. Private equity-backed companies: about 12,000 - Estimated count of PE-backed companies discussed. Average market cap of PE-backed companies: about $300 million - Illustrates the much smaller scale of private companies. Aggregate market cap of PE-backed companies: about $2.4-$2.5 trillion - Rough size of the private equity universe in equity terms. Typical PE leverage: 50% to 60% - Private equity deals are described as highly levered. Suggested 'reasonable' private market allocation: about 3.6% - Derived from a 60% equity allocation times a 6% private-market size versus S&P. Private equity distributions historically: about 30% of NAV per year - Typical distribution rate before the recent decline. Current PE distributions: about 10% of NAV per year - Lowest since 2008, indicating weak exits and liquidity. Listed private equity fund market price volatility: 24% annualized - Publicly traded PE fund shares were far more volatile than reported NAVs. Listed private equity NAV volatility: about 10% annualized - Reported NAV volatility is much lower than market-price volatility. Listed PE fund discount to NAV: 95 cents on the dollar in 2021; about 70 cents today - Shows widening public-market skepticism toward private equity valuations. Small-cap value in U.S. recovery periods: worked from COVID until GPT release - Dan notes a recent window where U.S. value performed better, especially in cyclical recovery phases. Biotech drawdown from peak: down about 60% - Illustrates the severity of pain in U.S. small-cap biotech. Capital intensity of big tech vs U.S. industrials: from one-third to 3x - AI-related hyperscalers moved from lower to much higher capital intensity relative to industrial companies.

Pivotal Quotes: "It's a money trap, right? The money's gone in. It's just not going to come out." — Dan Wang: On private equity liquidity and why the asset class may disappoint investors looking for realizable returns. "Investing is not a game of analysis. It's a game of meta analysis." — Dan Wang: Explaining that returns depend on being different from consensus, not just being analytically correct. "If I have a 15% weight, or a 30% weight, or God forbid, a 40% weight, I am massively, massively over-allocated to these 12,000 companies." — Dan Wang: On institutional portfolios being far too large relative to the size of the private equity universe.

Implications: Investors should question large private-equity allocations, expect lower liquidity and returns, and reassess volatility claims. The most attractive opportunities may be in unloved public small caps, while AI and innovation investing still require caution about capital intensity and bubble risk.